VA Office of Research and Development

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain

Phase 4

Terminated

Conditions: Pain

Interventions: Drug: buprenorphine/naloxone
Drug: opioid dose escalation

First Posted Date: 2013-06-12

Last Posted Date: 2016-12-21

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 7

Registration Number: NCT01875848

Locations: 🇺🇸
VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States

Mindfulness-Based Cognitive Therapy for Suicide Prevention

Not Applicable

Completed

Conditions: Suicide

Interventions: Behavioral: Treatment as usual
Behavioral: Mindfulness-Based Cognitive Therapy for Suicide

First Posted Date: 2013-06-07

Last Posted Date: 2020-05-05

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 135

Registration Number: NCT01872338

Locations: 🇺🇸
East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ, East Orange, New Jersey, United States
🇺🇸
Lyons Campus of the VA New Jersey Health Care System, Lyons, NJ, Lyons, New Jersey, United States

Spectral Dynamics and Speech Understanding by Hearing Impaired People

Not Applicable

Completed

Conditions: Hearing Loss, Sensorineural

Interventions: Other: Acoustic distortion of speech

First Posted Date: 2013-06-04

Last Posted Date: 2018-04-26

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 50

Registration Number: NCT01867515

Locations: 🇺🇸
VA Portland Health Care System, Portland, OR, Portland, Oregon, United States

Improving Autonomic Function and Balance in Diabetic Neuropathy

Not Applicable

Active, not recruiting

Conditions: Diabetes
Neuropathy
Impaired Glucose Tolerance

Interventions: Behavioral: lifestyle modification

First Posted Date: 2013-05-29

Last Posted Date: 2023-09-01

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 60

Registration Number: NCT01864460

Locations: 🇺🇸
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore, Maryland, United States

Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease

Phase 2

Completed

Conditions: Pulmonary Hypertension
Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Drug: placebo
Drug: Tadalafil

First Posted Date: 2013-05-24

Last Posted Date: 2021-03-09

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 44

Registration Number: NCT01862536

Locations: 🇺🇸
Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States
🇺🇸
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States
🇺🇸
VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States

and more 2 locations

Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: Peer Coaching
Behavioral: Decision Aid

First Posted Date: 2013-05-16

Last Posted Date: 2019-07-12

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 290

Registration Number: NCT01855399

Locations: 🇺🇸
VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States
🇺🇸
John D. Dingell VA Medical Center, Detroit, MI, Detroit, Michigan, United States

Translation of Eye Movement Reading Training to Clinical Practice

Not Applicable

Completed

Conditions: Macular Disease

Interventions: Behavioral: Platform for Administering Eye-movement Control Training

First Posted Date: 2013-05-15

Last Posted Date: 2019-11-13

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 33

Registration Number: NCT01853930

Locations: 🇺🇸
Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois, United States

Randomized Endo-Vein Graft Prospective

Not Applicable

Completed

Conditions: Coronary Artery Bypass Grafting

Interventions: Procedure: Vein Harvesting Procedures

First Posted Date: 2013-05-09

Last Posted Date: 2021-12-15

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 1150

Registration Number: NCT01850082

Locations: 🇺🇸
Southern Arizona VA Health Care System, Tucson, AZ, Tucson, Arizona, United States
🇺🇸
San Francisco VA Medical Center, San Francisco, CA, San Francisco, California, United States
🇺🇸
Miami VA Healthcare System, Miami, FL, Miami, Florida, United States

and more 13 locations

Research Examining Gulf War Illness in Our Nations Service Members

Phase 2

Terminated

Conditions: Gulf War Illness

Interventions: Drug: Placebo
Drug: Duloxetine
Drug: Pregabalin

First Posted Date: 2013-05-03

Last Posted Date: 2021-03-12

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 112

Registration Number: NCT01846182

Locations: 🇺🇸
Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX, Waco, Texas, United States
🇺🇸
Central Texas Veterans Health Care System, Temple, TX, Temple, Texas, United States

Improving Patient-centered Care Using an Inventory

Phase 2

Completed

Conditions: Primary Care

Interventions: Other: patient inventory
Other: attention control

First Posted Date: 2013-05-01

Last Posted Date: 2019-03-13

Lead Sponsor: VA Office of Research and Development

Target Recruit Count: 276

Registration Number: NCT01843803

Locations: 🇺🇸
Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States
🇺🇸
Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy